Paper81986
Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease.
O'Donoghue DP and 4 others. Lancet, 1978. Cited by 330 papers, by iCite.
Cite this record
ConductScience Library. Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease. Papers, record 81986. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/81986
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Azathioprine | Major topic |
| Crohn Disease | Major topic |
| Substance Withdrawal Syndrome | Major topic |
| Adult | |
| Aged | |
| Clinical Trials as Topic | |
| Double-Blind Method | |
| Drug Evaluation | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Male | |
| Middle Aged | |
| Placebos | |
| Recurrence | |
| Remission, Spontaneous | |
| Time Factors |
Source PubMed
Cited by73
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 330 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41274746 | AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe Crohn's Disease. | Gastroenterology | 2025 | https://conductscience.org/library/papers/41274746 | PubMed |
| 41095947 | Relapse Rates and Predictors Following Azathioprine Withdrawal in Inflammatory Bowel Disease: A Systematic Review, Meta-Analysis, and Meta-Regression. | J Clin Med | 2025 | https://conductscience.org/library/papers/41095947 | PubMed |
| 39200937 | Common Mistakes in Managing Patients with Inflammatory Bowel Disease. | J Clin Med | 2024 | https://conductscience.org/library/papers/39200937 | PubMed |
| 38589597 | Real-world NUDT15 genotyping and thiopurine treatment optimization in inflammatory bowel disease: a multicenter study. | J Gastroenterol | 2024 | https://conductscience.org/library/papers/38589597 | PubMed |
| 37545640 | Azathioprine monotherapy withdrawal in inflammatory bowel diseases: A retrospective mono-centric study. | World J Gastroenterol | 2023 | https://conductscience.org/library/papers/37545640 | PubMed |
| 36776499 | Normal Ranges of Thiopurine Methyltransferase Activity Do Not Affect Thioguanine Nucleotide Concentrations With Azathioprine Therapy in Inflammatory Bowel Disease. | Crohns Colitis 360 | 2020 | https://conductscience.org/library/papers/36776499 | PubMed |
| 36773075 | Treatment escalation and de-escalation decisions in Crohn's disease: Delphi consensus recommendations from Japan, 2021. | J Gastroenterol | 2023 | https://conductscience.org/library/papers/36773075 | PubMed |
| 35835862 | Relapse rates after withdrawal of thiopurines in patients with inflammatory bowel disease. | Int J Colorectal Dis | 2022 | https://conductscience.org/library/papers/35835862 | PubMed |
| 35687221 | Proactive Metabolite Testing in Patients on Thiopurine May Yield Long-Term Clinical Benefits in Inflammatory Bowel Disease. | Dig Dis Sci | 2023 | https://conductscience.org/library/papers/35687221 | PubMed |
| 35401955 | Pancreatitis associated with azathioprine and 6-mercaptopurine use in Crohn's disease: a systematic review. | Frontline Gastroenterol | 2021 | https://conductscience.org/library/papers/35401955 | PubMed |
| 34976235 | Guidelines for the management of patients with Crohn's disease. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology. | Prz Gastroenterol | 2021 | https://conductscience.org/library/papers/34976235 | PubMed |
| 33249621 | Systematic review with meta-analysis: the effects of immunomodulator or biological withdrawal from mono- or combination therapy in inflammatory bowel disease. | Aliment Pharmacol Ther | 2021 | https://conductscience.org/library/papers/33249621 | PubMed |
| 32591969 | Poor Drug Sustainability in Inflammatory Bowel Disease Patients in Clinical Remission on Thiopurine Monotherapy. | Dig Dis Sci | 2021 | https://conductscience.org/library/papers/32591969 | PubMed |
| 31364448 | Immunosuppressive therapies adversely affect blood biochemical parameters in patients with inflammatory bowel disease: a meta-analysis. | J Int Med Res | 2019 | https://conductscience.org/library/papers/31364448 | PubMed |
| 31146509 | Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia. | Intest Res | 2019 | https://conductscience.org/library/papers/31146509 | PubMed |
| 29980848 | The state of the art on treatment of Crohn's disease. | J Gastroenterol | 2018 | https://conductscience.org/library/papers/29980848 | PubMed |
| 29961926 | De-escalation of Therapy in Inflammatory Bowel Disease. | Curr Gastroenterol Rep | 2018 | https://conductscience.org/library/papers/29961926 | PubMed |
| 29756637 | Withdrawal of immunosuppressant or biologic therapy for patients with quiescent Crohn's disease. | Cochrane Database Syst Rev | 2018 | https://conductscience.org/library/papers/29756637 | PubMed |
| 26517527 | Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease. | Cochrane Database Syst Rev | 2015 | https://conductscience.org/library/papers/26517527 | PubMed |
| 26491502 | Combination Therapy With Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Refractory Ulcerative Colitis. | J Clin Med Res | 2015 | https://conductscience.org/library/papers/26491502 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/81986
GET https://conductscience.org/api/papers/v1/81986/cited_by?page=2